Organogenesis Holdings Valuation
| ORGO Stock | USD 2.98 0.01 0.34% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. Organogenesis Holdings holds a recent Real Value of $3.24 per share. The prevailing price of the company is $2.98. Our model determines the value of Organogenesis Holdings from analyzing the company fundamentals such as Operating Margin of 0.01 %, return on equity of 0.0182, and Shares Outstanding of 131.96 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors support obtaining undervalued entities and abandoning overvalued entities since, at some point, asset prices and their ongoing real values will merge together. Key fundamental drivers impacting Organogenesis Holdings' valuation include:
Price Book 1.3733 | Enterprise Value 411.1 M | Enterprise Value Ebitda 11.0517 | Price Sales 0.8774 | Forward PE 12.3153 |
Undervalued
Today
Please note that Organogenesis Holdings' price fluctuation is risky at this time. Calculation of the real value of Organogenesis Holdings is based on 3 months time horizon. Increasing Organogenesis Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Organogenesis Holdings is useful when determining the fair value of the Organogenesis stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Organogenesis Holdings. Since Organogenesis Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Organogenesis Stock. However, Organogenesis Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.98 | Real 3.24 | Target 3.5 | Hype 2.95 | Naive 2.82 |
The real value of Organogenesis Stock, also known as its intrinsic value, is the underlying worth of Organogenesis Holdings Company, which is reflected in its stock price. It is based on Organogenesis Holdings' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Organogenesis Holdings' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Organogenesis Holdings' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Organogenesis Holdings helps investors to forecast how Organogenesis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Organogenesis Holdings more accurately as focusing exclusively on Organogenesis Holdings' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Organogenesis Holdings' intrinsic value based on its ongoing forecasts of Organogenesis Holdings' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Organogenesis Holdings' closest peers. When choosing an evaluation method for Organogenesis Holdings, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Organogenesis Holdings Investments |
|
Organogenesis Valuation Trend
Knowing Organogenesis Holdings' actual value is paramount for traders to make sound investment determinations. Organogenesis Holdings' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Organogenesis Holdings' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Organogenesis Holdings' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Organogenesis Market Cap
Organogenesis Holdings is regarded second in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 2.45 Billion. Organogenesis Holdings retains roughly 393.25 Million in market capitalization claiming about 16% of equities under Health Care industry.Organogenesis Holdings Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Organogenesis Holdings's current stock value. Our valuation model uses many indicators to compare Organogenesis Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Organogenesis Holdings competition to find correlations between indicators driving Organogenesis Holdings's intrinsic value. More Info.Organogenesis Holdings is considered to be number one stock in price to earning category among related companies. It is regarded third in price to book category among related companies fabricating about 0.08 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Organogenesis Holdings is roughly 12.47 . As of the 25th of April 2024, Price To Book Ratio is likely to drop to 1.83. Comparative valuation analysis is a catch-all model that can be used if you cannot value Organogenesis Holdings by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Organogenesis Holdings' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Organogenesis Holdings' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Organogenesis Holdings' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Organogenesis Holdings and how it compares across the competition.
About Organogenesis Holdings Valuation
The stock valuation mechanism determines the current worth of Organogenesis Holdings on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Organogenesis Holdings. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Organogenesis Holdings based exclusively on its fundamental and basic technical indicators. By analyzing Organogenesis Holdings's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Organogenesis Holdings's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Organogenesis Holdings. We calculate exposure to Organogenesis Holdings's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Organogenesis Holdings's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 309.8 M | 178 M | |
| Pretax Profit Margin | 0.02 | 0.03 | |
| Operating Profit Margin | 0.04 | 0.04 | |
| Net Profit Margin | 0.01 | 0.01 | |
| Gross Profit Margin | 0.72 | 0.58 |
8 Steps to conduct Organogenesis Holdings' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Organogenesis Holdings' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Organogenesis Holdings' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Organogenesis Holdings' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Organogenesis Holdings' revenue streams: Identify Organogenesis Holdings' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Organogenesis Holdings' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Organogenesis Holdings' growth potential: Evaluate Organogenesis Holdings' management, business model, and growth potential.
- Determine Organogenesis Holdings' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Organogenesis Holdings' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Organogenesis Holdings Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Organogenesis Holdings does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 132.7 M | |
| Quarterly Earnings Growth Y O Y | 11.307 | |
| Forward Price Earnings | 12.3153 |
Organogenesis Holdings Current Valuation Indicators
Valuation refers to the process of determining the present value of Organogenesis Holdings and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Organogenesis we look at many different elements of the entity such as Organogenesis's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Organogenesis Holdings' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Organogenesis Holdings' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Organogenesis Holdings, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Organogenesis Holdings' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Organogenesis Holdings' worth.When determining whether Organogenesis Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organogenesis Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organogenesis Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organogenesis Holdings Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organogenesis Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.Note that the Organogenesis Holdings information on this page should be used as a complementary analysis to other Organogenesis Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Organogenesis Stock analysis
When running Organogenesis Holdings' price analysis, check to measure Organogenesis Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organogenesis Holdings is operating at the current time. Most of Organogenesis Holdings' value examination focuses on studying past and present price action to predict the probability of Organogenesis Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organogenesis Holdings' price. Additionally, you may evaluate how the addition of Organogenesis Holdings to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is Organogenesis Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.307 | Earnings Share 0.04 | Revenue Per Share 3.301 | Quarterly Revenue Growth (0.14) | Return On Assets 0.0224 |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.